COMPANY SUMMARY:
 
Cygnal, a new biology platform company, was founded by Flagship Pioneering to pioneer the field of exoneural biology – the impact of the peripheral nervous system on cancer, the immune system, metabolism, and regeneration. The company is applying cutting-edge neuroscience to elucidate novel therapies to treat cancer progression and metastasis, autoimmune conditions, inflammation, and other diseases.

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.4 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions. The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

The Position

Cygnal is seeking a Scientist who is committed to impacting patient lives’ through discovering novel and effective therapeutics. The candidate will have the opportunity to work on a lead optimization stage immuno-oncology program, generating experimental data that directly informs critical decisions for project teams.  Key activities include understanding target biology, therapeutic mechanisms of action, response/resistance biomarkers, patient selection and rational combination strategies. Successful candidates will also have the opportunity to expand their skill set by working in a matrixed, cross-functional team setting, learning to bridge preclinical research to clinical translation and by attending various symposia and conferences.

Skills & Abilities

  • Ability to independently design, execute, interpret and troubleshoot experiments required
  • Strong experimental skills, especially in assay development, cell and molecular immunology required
  • Expertise in multi-color flow cytometry and immune cell phenotyping required
  • Expertise in primary immune cell isolation techniques and in vitro immune cell functional assays required
  • Experience with cytokine determination techniques like ELISA, Legendplex, qPCR required
  • Strong data analysis skills
  • Must be independent, goal-oriented and efficiently multi-task
  • Prior research experience in immune oncology a strong plus
  • Familiarity with emerging new science and/or technologies
  • Motivated and curious, experienced working with highly technical projects and personnel
  • Excellent communication and presentation skills, capable of conveying technical information in a clear and thorough manner
  • Strong organizational skills

Education & Experience

  • BS/MS with 4-5 years of relevant industry or academic experience
  • PhD in biology, immunology, or related fields with 0-1 years of experience
RECRUITING & STAFFING AGENCIES:
 
Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

Apply for this Job

* Required
  
  
When autocomplete results are available use up and down arrows to review
+ Add Another Education